Prevention of Chemotherapy-Induced Ovarian Failure With Goserelin in Premenopausal Lymphoma Patients
Latest Information Update: 21 Mar 2024
At a glance
- Drugs Goserelin (Primary) ; Antineoplastics
- Indications Chemotherapy-induced damage; Primary ovarian insufficiency
- Focus Therapeutic Use
- 17 Mar 2024 Planned End Date changed from 1 Nov 2023 to 1 Nov 2024.
- 08 Dec 2022 Planned End Date changed from 1 Jun 2023 to 1 Nov 2023.
- 07 Dec 2021 Status changed from completed to recruiting.